06127
- 即時昭衍新藥
- 21.640-0.540 (-2.435%)
- 營業額 / 收益
- 除稅前溢利 / (虧損)
- 股東應佔溢利 / (虧損)
- 每股盈利
- 668,575
- -21.285%
- 2,018,334
- 2,376,487
- 2,267,971
- 1,516,680
- (563,580)
- -11.672%
- (1,512,794)
- (1,397,094)
- (1,186,543)
- (781,002)
- 104,995
- -50.310%
- 505,540
- 979,393
- 1,081,428
- 735,678
- 94,977
- --
- (122,942)
- (288,807)
- 333,073
- 125,323
- 0
- --
- (559)
- (3,069)
- (2,691)
- (426)
- 80,119
- --
- 104,039
- 506,951
- 1,240,002
- 642,004
- (19,187)
- --
- (34,284)
- (115,398)
- (166,802)
- (85,587)
- 60,932
- --
- 74,075
- 396,993
- 1,074,257
- 557,460
- (40,547)
- -32.850%
- (100,783)
- (139,361)
- (127,651)
- (79,762)
- 76,519
- 26.263%
- 145,088
- 142,132
- 129,716
- 104,411
- --
- --
- 8,325
- 10,568
- 12,447
- 9,893
- 不適用
- --
- 無保留意見
- 無保留意見
- 無保留意見
- 無保留意見
市場價值指標
- 8.000
- --
- 10.000
- 53.000
- 144.000
- 77.143
- 0.000
- --
- 3.000
- 16.000
- 28.571
- 18.367
- --
- --
- 30.000%
- 30.189%
- 19.841%
- 23.810%
- 10.862
- --
- 10.779
- 11.041
- 10.912
- 9.550